共 50 条
- [31] Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II studyMEDICAL ONCOLOGY, 2018, 35 (07)Nishimoto, KojiKarayama, MasatoInui, NaokiYasui, HidekiHozumi, HironaoSuzuki, YuzoFuruhashi, KazukiFujisawa, TomoyukiEnomoto, NoriyukiNakamura, YutaroInami, NaoMatsuura, ShunKaida, YusukeMatsui, TakashiAsada, KazuhiroMatsuda, HiroyukiFujii, MasatoToyoshima, MikioImokawa, ShiroSuda, Takafumi
- [32] Pemetrexed - First-Line Therapy for Non-Squamous Non-Small Cell Lung Cancer: A Review of Patent LiteratureRECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2021, 16 (03) : 333 - 349Vora, Pratik AshwinbhaiPatel, RakeshDharamsi, Abhay
- [33] An extended overall survival analysis of pemetrexed and carboplatin with or without pembrolizumab as first-line therapy for advanced non-squamous non-small cell lung cancerANNALS OF TRANSLATIONAL MEDICINE, 2019, 7Afzal, Muhammad ZubairDragnev, Konstantin H.Shirai, Keisuke
- [34] First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trialEUROPEAN RESPIRATORY JOURNAL, 2020, 56 (02)Lavole, ArmelleGreillier, LaurentMazieres, JulienMonnet, IsabelleKiakouama-Maleka, LizeQuantin, XavierSpano, Jean PhilippeLena, HerveFraisse, PhilippeJanicot, HenriAudigier-Valette, ClarisseLanglais, AlexandraMorin, FranckMakinson, AlainCadranel, Jacques
- [35] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (≥75-years-old) with advanced non-squamous, non-small cell lung cancerEUROPEAN JOURNAL OF CANCER, 2015, 51 : S196 - S196Tamiya, M.Tamiya, A.Kaneda, H.Nakagawa, K.Goto, K.Yoh, K.Okamoto, H.Shimokawa, T.Abe, T.Tanaka, H.Daga, H.Takeda, K.Atagi, S.Hirashima, T.
- [36] SAFETY AND RESOURCE USE IN PRONOUNCE: A RANDOMIZED, PHASE 3, OPEN-LABEL STUDY OF PEMETREXED PLUS CARBOPLATIN WITH MAINTENANCE PEMETREXED (PEMC) AND PACLITAXEL PLUS CARBOPLATIN PLUS BEVACIZUMAB WITH MAINTENANCE BEVACIZUMAB (PCB) IN PATIENTS WITH ADVANCED NON-SQUAMOUS (NS) NON-SMALL-CELL LUNG CANCER (NSCLC)JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S578 - S578Ross, Helen J.Spigel, DavidWeaver, Robert W.Govindan, RamaswamyHolden, ViranChowhan, Naveed M.Beck, ThaddeusWaterhouse, DavidModiano, Manuel R.Rao, Vijay P.Winfree, Katherine B.Melemed, SymanthaLiu, JingyiKoustenis, Andrew G.Guba, Susan C.Ortuzar, Waldo I.Obasaju, ColemanZinner, Ralph
- [37] An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East AsiaASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 : 13 - 21Chang, John Wen-ChengThongprasert, SumitraWright, ElaineTsang, KennethKim, Heung TaeAhn, Myung-JuKim, Joo-HangKang, Jin HyoungKim, Sang-WeWalzer, Stefan
- [38] Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancerBIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (08) : 763 - 769Xu, BeiLiu, PengYin, YongmeiLiu, PingShu, Yongqian
- [39] EFFICACY OF CARBOPLATIN, PEMETREXED AND BEVACIZUMAB FOLLOWED BY MAINTENANCE GEFITINIB IN ADVANCED NON-SQUAMOUS NON SMALL CELL LUNG CANCER - A STUDY FROM NORTH INDIAJOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1179 - S1180Aggarwal, ShyamBasu, A.Bhalla, S.Shokeen, Y.Negi, A.Kohli, S.Jain, N.
- [40] Feasibility study of pemetrexed (PEM) plus bevacizumab (BV) as the first-line treatment for elderly advanced or recurrent non-squamous (non-Sq) non-small cell lung cancer (NSCLC): TORG1015JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Kozuki, ToshiyukiNogami, NaoyukiKitajima, HiromotoShinkai, TetsuKato, FumiakiSakaida, EmikoTakiguchi, YuichiIkeda, SatoshiYoshida, MasahiroEnomoto, YasunoriKato, TerufumiOgura, TakashiMiyamoto, ShingoMorita, SatoshiWatanabe, Koshiro